Pricing Log in Create free account

Ardelyx, Inc. (ARDX) vs Nuvectis Pharma, Inc. (NVCT)

Ardelyx, Inc. and Nuvectis Pharma, Inc. are both Biotechnology companies. Ardelyx, Inc. and Nuvectis Pharma, Inc. are of similar size ($786.8M and $722.2M). Nuvectis Pharma, Inc. has the higher net margin (0.00% vs −11.9%) and the higher return on invested capital (0.00% vs −17.2%). Across the 13 metrics below, Nuvectis Pharma, Inc. leads on 8 and Ardelyx, Inc. on 5.

Valuation

Metric ARDX NVCT Biotechnology median
P/E n/m n/m 11.58
P/S 1.68 n/m 9.61
P/B 4.79 4.90 2.26
Price to free cash flow n/m n/m 26.41
EV/EBITDA n/m n/m 0.72
EV/Sales 1.66 n/m 9.43
Earnings yield (7.10%) (8.97%) (32.28%)
Free cash flow yield (2.03%) (6.49%) (22.27%)

Profitability

Metric ARDX NVCT Biotechnology median
Gross margin 94.46% — 68.81%
Operating margin (7.71%) 0.00% 0.00%
Net margin (11.85%) 0.00% 0.00%
Free cash flow margin (3.41%) 0.00% 0.00%
Return on equity (34.85%) (66.98%) (50.30%)
Return on assets (10.33%) (57.20%) (45.47%)
Return on invested capital (17.21%) 0.00% 0.00%

Growth

Metric ARDX NVCT Biotechnology median
Revenue growth (TTM) 17.57% — 6.78%
EPS growth (last fiscal year) (52.94%) (18.92%) 29.88%
Revenue growth, 5-year CAGR 121.90% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ARDX NVCT Biotechnology median
Debt to equity 1.54 0.00 0.00
Current ratio 3.45 9.92 4.74
Net debt to EBITDA 1.63 1.15 1.01

Dividend

Metric ARDX NVCT Biotechnology median
Dividend yield — — 0.39%
Payout ratio — — —

Size

Metric ARDX NVCT Biotechnology median
Market cap 786.79m 722.17m 168.63m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack